Lung Cancer News

Mouth test could predict lung cancer, study finds - Mon, 14 Apr 2008

Source: Yahoo News

Researchers from the MD Anderson Cancer Center at the University of Texas at Houston recently announced the results of study they conducted that showed that damage to particular cells that line the mouth is often indicative of damage to similar cells in the lungs and is potentially predictive of the development of tobacco-induced lung cancer, as well as other forms of cancer that tobacc...

- Sat, 01 Mar 2008

Pemetrexed Plus Cisplatin Neoadjuvant Therapy Followed By Surgery and Radiation in Mesothelioma

Phase II trial of Neoadjuvant Chemotherapy with Pemetrexed plus Cisplatin followed by Surgery and Radiotherapy in patients with...

Low-dose Computed Tomography Screening for Lung Cancer and Pleural Mesothelioma in an Asbestos-Exposed Population - Fri, 15 Feb 2008

Source: The Oncologist

Advances in imaging technologies have had a lasting impact on medical science. Better imaging techniques let doctors diagnose disease in a much more efficient manner and higher resolution scans can often be the difference between life and death. These advances are important to cancer research, especially to rese...

Utility of WT-1, p63, MOC31, Mesothelin, and Cytokeratin (K903 and CK5/6) Immunostains - Fri, 11 Jan 2008

Source: Utility of WT-1, p63, MOC31, Mesothelin, and Cytokeratin (K903 and CK5/6) Immunostains in Differentiating Adenocarcinoma, Squamous Cell Carcinoma, and
(Diagn Cytopathol. 2008 Jan;36(1):20-5)

The first step in a diagnosis of cancer is the definitive conclusion of the presence of malignant tissue. However, this tissue may not identify th...

Pseudomesotheliomatous Adenocarcinoma of the Lung with Synchronous Gastric and Esophageal Cancer - Wed, 26 Dec 2007

Source: Australasian Radiology

One of the most difficult aspects of treating cancer is the distinct number of forms it can take. While most cancers follow particular biological patterns, the literature is full of examples that do not follow these general trends. For example, in patients who present with a number of different tumors,...

Mortality among shipyard Coast Guard workers: a retrospective cohort study - Mon, 15 Oct 2007

Source: Occupational and Environmental Medicine

Asbestos exposure is a constant concern for workers in shipyards. There is evidence to suggest that these workers are much more likely to come down with an asbestos-related disease than other professions. A study looking at the health patterns of a group of 4702 workers of a Coast Guard shipyard was recently completed and the results did show a greater mortalit...

Lilly Files for European Approval of ALIMTA® (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer - Fri, 21 Sep 2007

Source: Eli Lilly

Eli Lilly has submitted an application with the European Medicines Agency (EMEA) for the approval of Alimta^®, in combination with cisplatin, as a first-line treatment for advanced non-small cell lung cancer (NSCLC). The EMEA has previously approved Alimta as a single agent, second-line therapy for advanced NSCLC.

The submission is based on the results of a...

Herbs, Massage or Hypnosis? Cancer Patients Get Advice - Tue, 11 Sep 2007

Source: Wall Street Journal

In a supplement published in the medical journal Chest, the American College of Chest Physicians offered the first comprehensive analysis on the use of alternative and complementary medicine in the treatment of lung cancer. The researchers examined over 100 published studies regarding alternative or complementary medicine in an attempt to quantify the benefits and to ident...

WHO Calls for Prevention of Cancer Through Healthy Workplaces - Fri, 04 May 2007

Source: World Health Organization

The World Health Organization is calling on governments to enact meaningful reform to workplace safety laws and to increase the measures used to protect workers from work-related injury or death. At least 200,000 people die every year from work-caused cancers and millions more are regularly exposed to carcinogenic agents that can dramatically shorten ...

New Methods for Treating Lung Cancer Cells that have become Resistant to New Anti-Cancer Agents - Wed, 25 Apr 2007

Source: News-Medical.Net

Researches from the Ireland Cancer Center have discovered a mutation in the epidermal growth factor protein (EGFR) that causes resistance in lung cancer cells to targeting agents, such as Tarceva, that attempt to halt the spread of cancer cells by disrupting the receptor responsible for tumor growth. Tarceva has been successfully deployed in clinical settings, with approximately 10 pe...